Optimal Medical Care

PreclinicalSmall molecule

RRadboud University Medical Center

Optimal Medical Care is one of 2 small molecule programs targeting Mindfulness. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

MindfulnessCompleted

MindfulnessPreclinical

Completed

Competition

Competitive Landscape

1 competitor in Mindfulness

#DrugCompanyPhaseTrials

Ketalar

AAultman Health Foundation

Phase 2

2 2

Optimal Medical Care

RRadboud University Medical Center

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Mindfulness1 trial

Mindfulness Based Cognitive Therapy and Antidepressant Medication in Recurrent Depression

Completed·RRadboud University Medical Center·N/A·NCT00928980·317 enrolled

Unspecified1 trial

Sonodynamic Therapy on Patients With Femoropopliteal PAD and Claudication

Withdrawn·FFirst Affiliated Hospital of Harbin Medical University·Phase 1/2·NCT03318484

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Optimal Medical Care. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Optimal Medical Care compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Optimal Medical Care. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Radboud University Medical Center company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: RRadboud University Medical Center

Optimal Medical Care

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Mindfulness1 trial

Unspecified1 trial

References

Drug Info

Quick Facts

Related News